Background: F-fluorodeoxyglucose (F-FDG) positron emission tomography (PET) is used in the diagnosis and management of patients with cardiac sarcoidosis (CS). Various preparation protocols have been proposed to minimise myocardial F-FDG uptake and improve scan readability. The aim of this systematic review was to identify the optimal dietary prescription for suppression of physiological F-FDG myocardial uptake to enhance clinical diagnosis of CS. Methods and Results: MEDLINE and PubMed databases identified 13 studies meeting inclusion criteria for review. Articles were assessed using the Australian National Health and Medical Research Council levels of evidence and categorised as sarcoidosis (human) or non-sarcoidosis (human, animal). Visua...
Adequate suppression of cardiac glucose metabolism increases the interpretability and diagnostic rel...
AbstractObjectives18F-fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomograph...
Background: Positron emission tomography (PET) with 18F fluorodeoxyglucose (FDG) is used in evaluati...
INTRODUCTION: Suppression of physiological myocardial FDG activity is vital in patients undergoing P...
Background: 18F-fluorodeoxyglucose (FDG) PET/CT plays an important role to detect active cardiac inv...
(18)F-fluorodeoxyglucose (FDG) PET plays an important role in the detection of cardiac involvement s...
Cardiac sarcoidosis is considered to be a significant cause of advanced atrioventricular (AV) block ...
lntroduction: Cardiac positron emission tomography (PET) using F18-fluorodeoxyglucose (FDG) has been...
Objectives: In this educational exhibit, we study quantitative approaches to assess adequate metabol...
PURPOSE: This study aimed to prospectively investigate F-FDG PET/CT role for the assessment of sarco...
Sarcoidosis is a multisystem disorder with cardiac invol-vement in 25 % of cases [1]. Diagnosis of c...
Low-carbohydrate (LC) and high-fat, low-carbohydrate (HFLC) dietary preparations may enhance 18F-FDG...
Introduction: Adequate suppression of physiologic myocardial glucose uptake is important to ensure t...
Objective(s): Physiological myocardial 18F-fluorodeoxyglucose (18F-FDG) uptake in oncologic positron...
Abstract Background 18F-FDG PET has been used in sarcoidosis for diagnosis and determination of the ...
Adequate suppression of cardiac glucose metabolism increases the interpretability and diagnostic rel...
AbstractObjectives18F-fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomograph...
Background: Positron emission tomography (PET) with 18F fluorodeoxyglucose (FDG) is used in evaluati...
INTRODUCTION: Suppression of physiological myocardial FDG activity is vital in patients undergoing P...
Background: 18F-fluorodeoxyglucose (FDG) PET/CT plays an important role to detect active cardiac inv...
(18)F-fluorodeoxyglucose (FDG) PET plays an important role in the detection of cardiac involvement s...
Cardiac sarcoidosis is considered to be a significant cause of advanced atrioventricular (AV) block ...
lntroduction: Cardiac positron emission tomography (PET) using F18-fluorodeoxyglucose (FDG) has been...
Objectives: In this educational exhibit, we study quantitative approaches to assess adequate metabol...
PURPOSE: This study aimed to prospectively investigate F-FDG PET/CT role for the assessment of sarco...
Sarcoidosis is a multisystem disorder with cardiac invol-vement in 25 % of cases [1]. Diagnosis of c...
Low-carbohydrate (LC) and high-fat, low-carbohydrate (HFLC) dietary preparations may enhance 18F-FDG...
Introduction: Adequate suppression of physiologic myocardial glucose uptake is important to ensure t...
Objective(s): Physiological myocardial 18F-fluorodeoxyglucose (18F-FDG) uptake in oncologic positron...
Abstract Background 18F-FDG PET has been used in sarcoidosis for diagnosis and determination of the ...
Adequate suppression of cardiac glucose metabolism increases the interpretability and diagnostic rel...
AbstractObjectives18F-fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomograph...
Background: Positron emission tomography (PET) with 18F fluorodeoxyglucose (FDG) is used in evaluati...